Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31357157 | 0.81 | PTPN1 (0.70) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL70015 | 0.79 | PTPN1 (1.00) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL343608 | 0.79 | MEN1 (0.52) | PTPN1MEN1KMT2AGRIN2DGRIN2A | |
| SCHEMBL186327 | 0.79 | PTPN1 (0.68) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL29404396 | 0.79 | PTPN1 (1.00) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL5664701 | 0.78 | PTPN1 (0.66) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL341301 | 0.78 | PTPN1 (0.66) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL3106132 | 0.78 | PTPN1 (0.66) | PTPN1MEN1KMT2ACA12CA1 | |
| Hydrochloric Acid SCHEMBL8522902 | 0.78 | PTPN1 (0.96) | PTPN1MEN1KMT2ACA12CA1 | |
| SCHEMBL29397498 | 0.78 | PTPN1 (0.66) | PTPN1MEN1KMT2ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2420538-B1 | PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED BODY | NIPPON KAYAKU KK (JP) | 2015-04-22 | — | — | EP | disclosed |
| US-8535431-B2 | Porphyrazine coloring matter, ink composition containing the same and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-09-17 | — | — | US | disclosed |
| US-8535432-B2 | Porphyrazine coloring matter, ink composition containing the same and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-09-17 | — | — | US | disclosed |
| EP-2371906-B1 | PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED MATERIAL | NIPPON KAYAKU KK (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2420538-A1 | PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED BODY | Nippon Kayaku Kabushiki Kaisha (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120013678-A1 | Porphyrazine Coloring Matter, Ink Composition Containing The Same And Colored Product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20110242198-A1 | Porphyrazine Coloring Matter, Ink Composition Containing The Same And Colored Product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| EP-2371906-A1 | PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED MATERIAL | Nippon Kayaku Kabushiki Kaisha (JP) | 2011-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110242198-A1 | Porphyrazine Coloring Matter, Ink Composition Containing The Same And Colored Product | PPOX, JAK1, IL5 | PTPN1 20/4885MEN1 3558/4885KMT2A 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.